These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24573695)

  • 1. ZEB2-transgene expression in the epidermis compromises the integrity of the epidermal barrier through the repression of different tight junction proteins.
    Tatari MN; De Craene B; Soen B; Taminau J; Vermassen P; Goossens S; Haigh K; Cazzola S; Lambert J; Huylebroeck D; Haigh JJ; Berx G
    Cell Mol Life Sci; 2014 Sep; 71(18):3599-609. PubMed ID: 24573695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal tight junctions: ZO-1 and occludin are expressed in mature, developing, and affected skin and in vitro differentiating keratinocytes.
    Pummi K; Malminen M; Aho H; Karvonen SL; Peltonen J; Peltonen S
    J Invest Dermatol; 2001 Nov; 117(5):1050-8. PubMed ID: 11710912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
    Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
    Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
    He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
    Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TFAP2A is a component of the ZEB1/2 network that regulates TGFB1-induced epithelial to mesenchymal transition.
    Dimitrova Y; Gruber AJ; Mittal N; Ghosh S; Dimitriades B; Mathow D; Grandy WA; Christofori G; Zavolan M
    Biol Direct; 2017 Apr; 12(1):8. PubMed ID: 28412966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cell maturation is accompanied by induction of N-cadherin and the transcriptional regulators of epithelial-mesenchymal transition ZEB1/2.
    Konradi S; Yasmin N; Haslwanter D; Weber M; Gesslbauer B; Sixt M; Strobl H
    Eur J Immunol; 2014 Feb; 44(2):553-60. PubMed ID: 24165969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signaling.
    Li J; Riedt T; Goossens S; Carrillo García C; Szczepanski S; Brandes M; Pieters T; Dobrosch L; Gütgemann I; Farla N; Radaelli E; Hulpiau P; Mallela N; Fröhlich H; La Starza R; Matteucci C; Chen T; Brossart P; Mecucci C; Huylebroeck D; Haigh JJ; Janzen V
    Blood; 2017 Jan; 129(4):460-472. PubMed ID: 27683414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZEB2, a master regulator of the epithelial-mesenchymal transition, mediates trophoblast differentiation.
    DaSilva-Arnold SC; Kuo CY; Davra V; Remache Y; Kim PCW; Fisher JP; Zamudio S; Al-Khan A; Birge RB; Illsley NP
    Mol Hum Reprod; 2019 Feb; 25(2):61-75. PubMed ID: 30462321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
    Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
    Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia.
    Li H; Mar BG; Zhang H; Puram RV; Vazquez F; Weir BA; Hahn WC; Ebert B; Pellman D
    Blood; 2017 Jan; 129(4):497-508. PubMed ID: 27756750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.
    Ren D; Wang M; Guo W; Huang S; Wang Z; Zhao X; Du H; Song L; Peng X
    Cell Tissue Res; 2014 Dec; 358(3):763-78. PubMed ID: 25296715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin ligase Cbl-b represses IGF-I-induced epithelial mesenchymal transition via ZEB2 and microRNA-200c regulation in gastric cancer cells.
    Li H; Xu L; Li C; Zhao L; Ma Y; Zheng H; Li Z; Zhang Y; Wang R; Liu Y; Qu X
    Mol Cancer; 2014 Jun; 13():136. PubMed ID: 24885194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization.
    Goossens S; Janzen V; Bartunkova S; Yokomizo T; Drogat B; Crisan M; Haigh K; Seuntjens E; Umans L; Riedt T; Bogaert P; Haenebalcke L; Berx G; Dzierzak E; Huylebroeck D; Haigh JJ
    Blood; 2011 May; 117(21):5620-30. PubMed ID: 21355089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes.
    Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J
    Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.
    Ohashi S; Natsuizaka M; Naganuma S; Kagawa S; Kimura S; Itoh H; Kalman RA; Nakagawa M; Darling DS; Basu D; Gimotty PA; Klein-Szanto AJ; Diehl JA; Herlyn M; Nakagawa H
    Cancer Res; 2011 Nov; 71(21):6836-47. PubMed ID: 21890822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZEB2 promotes the metastasis of gastric cancer and modulates epithelial mesenchymal transition of gastric cancer cells.
    Dai YH; Tang YP; Zhu HY; Lv L; Chu Y; Zhou YQ; Huo JR
    Dig Dis Sci; 2012 May; 57(5):1253-60. PubMed ID: 22350782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression.
    Denecker G; Vandamme N; Akay O; Koludrovic D; Taminau J; Lemeire K; Gheldof A; De Craene B; Van Gele M; Brochez L; Udupi GM; Rafferty M; Balint B; Gallagher WM; Ghanem G; Huylebroeck D; Haigh J; van den Oord J; Larue L; Davidson I; Marine JC; Berx G
    Cell Death Differ; 2014 Aug; 21(8):1250-61. PubMed ID: 24769727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition.
    Beltran M; Puig I; Peña C; García JM; Alvarez AB; Peña R; Bonilla F; de Herreros AG
    Genes Dev; 2008 Mar; 22(6):756-69. PubMed ID: 18347095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.